Predictive Pre-Cancerous Biomarkers in BRCA1/2 Mutation Carriers: From Tissue-Resident Pre-CAFs to Blood-Based Exosomal Cargo
Article Information
Publication Timeline
- Received23 May 2026
- Accepted20 June 2026
- Published
Abstract
BRCA1 and BRCA2 mutations are associated with a high lifetime risk of breast and ovarian cancer, and require close monitoring. The sensitivity of current imaging sense modality is limited, and the tissue biopsy is ethically and practically difficult in asymptomatic patients. Recent advances have identified a unique population of pre-cancer associated fibroblasts (pre-CAFs) that are characterised by dual overexpression of Podoplanin (PDPN) and CD10 (PodPDPN/CD10) in histologically normal breast tissue from BRCA1/2 carriers, the earliest stromal remodelling event prior to malignant transformation. This tissue-based signature offers insights into mechanisms, but is hampered by the need for invasive sampling for clinical use. This review summarizes the current state of the art of non-invasive liquid biopsy alternatives, such as soluble PDPN (sPDPN), cell-free DNA (cfDNA) methylation signatures, and, most promisingly, exosomal microRNA (miRNA) cargo. We emphasize that although circulating free miRNA is highly unstable, exosomal lipid bilayer vesicles provide biological protection and allow for paracrine/endocrine reprogramming of distant epithelial cells. The future of stromal biology and exosomal transcriptomics is one in which a simple blood test may be able to predict the onset of carcinogenesis in high-risk BRCA1/2 populations, leading to truly personalised prevention.
Keywords
BRCA1BRCA2Pre-CancerPDPNCD10Cancer-Associated FibroblastsLiquid BiopsyExosomescfDNA MethylationMicroRNAReferences
- Abdel-Razeq H, Mansour R. Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants. World J Oncol. 2026;17(1):14-24. [Google Scholar][Crossref]
- Mavaddat N, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105(11):812-22. [Google Scholar][Crossref]
- Schrijver LH, et al. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. J Natl Cancer Inst. 2022;114(4):540-552. [Google Scholar][Crossref]
- Nyberg T, et al. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study. Eur Urol. 2020;77(1):24-35. [Google Scholar][Crossref]
- O'Reilly C, et al. Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis. JAMA Surg. 2026;161(3):260-267. [Google Scholar][Crossref]
- Gordhandas S, et al. Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations. Gynecol Oncol. 2025;193:20-23. [Google Scholar][Crossref]
- Jerjes W, Majeed A. Time for a change: doctors should begin with a clock rather than a diagnosis. Postgrad Med J. 2026. [Google Scholar][Crossref]
- Suzuki-Inoue K, Osada M, Ozaki Y. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood. J Thromb Haemost. 2017;15(2):219-229. [Google Scholar][Crossref]
- Wang Z, et al. Podoplanin-defined tumour plasticity and CCR7-mediated lymphatic metastasis in triple-negative breast cancer. Br J Cancer. 2026;134(12):1730-1743. [Google Scholar][Crossref]
- Abd Zaid Al Abedi R. Urban Residence and Genetic Predisposition Underlying Breast Cancer Distribution in Iraq. Indonesian Journal on Health Science and Medicine. 2026;3(1):10.21070/ijhsm.v3i1.486. [Google Scholar][Crossref]
- Tanaka Y, et al. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2-negative subtype. Breast Cancer. 2021;28(4):822-828. [Google Scholar][Crossref]
- Solek J, et al. FGFR-related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review). Int J Oncol. 2024;65(4). [Google Scholar][Crossref]
- Jana SH, et al. CD10-a new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis. Indian J Pathol Microbiol. 2014;57(4):530-6. [Google Scholar][Crossref]
- Su S, et al. CD10(+)GPR77(+) Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172(4):841-856.e16. [Google Scholar][Crossref]
- Patil VS, Barate S. CD10 Immunohistochemical Expression in Breast Carcinoma and Its Correlation With Clinicopathological Parameters. Cureus. 2024;16(8):e67279. [Google Scholar][Crossref]
- Altman JE, et al. Single-cell transcriptional atlas of human breast cancers and model systems. Clin Transl Med. 2024;14(10):e70044. [Google Scholar][Crossref]
- Gupta P, et al. Single-cell spatial atlas of the aging human breast. Nat Aging. 2026;6(4):916-931. [Google Scholar][Crossref]
- Reed AD, et al. A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast. Nat Genet. 2024;56(4):652-662. [Google Scholar][Crossref]
- Chen A, et al. A highly resolved integrated single-cell atlas of human breast cancers. NAR Genom Bioinform. 2026;8(1):lqaf217. [Google Scholar][Crossref]
- De Leonardis F, et al. Healthy BRCA1/2 mutation carriers exhibit a pre-CAF signature and altered epithelial marker expression in breast tissue. Sci Rep. 2025;15(1):32736. [Google Scholar][Crossref]
- Nee K, et al. Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis. Nat Genet. 2023;55(4):595-606. [Google Scholar][Crossref]
- Mendes S, et al. Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo-Oophorectomy in BRCA1/2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center. Cancer Med. 2026;15(3):e71691. [Google Scholar][Crossref]
- Keup C, Kimmig R, Kasimir-Bauer S. The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management. Cancers (Basel). 2023;15(22). [Google Scholar][Crossref]
- Cieslik SA, et al. Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer. J Exp Clin Cancer Res. 2025;44(1):9. [Google Scholar][Crossref]
- Dhar R, Devi A. Exosomes Barcoding: A smart approach for cancer liquid biopsy. J Liq Biopsy. 2023;2:100129. [Google Scholar][Crossref]
- Zhu X, et al. The Detection of Plasma Soluble Podoplanin of Patients with Breast Cancer and Its Clinical Signification. Cancer Manag Res. 2020;12:13207-13214. [Google Scholar][Crossref]
- Moraes CRP, et al. Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia. Hematol Transfus Cell Ther. 2026;48(1):106227. [Google Scholar][Crossref]
- Zhao X, et al. Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis. Cancer Sci. 2018;109(2):403-411. [Google Scholar][Crossref]
- Ahn S, et al. Mammography-based deep learning model for coronary artery calcification. Eur Heart J Cardiovasc Imaging. 2024;25(4):456-466. [Google Scholar][Crossref]
- Xiang H, et al. Integrative Mendelian Randomization and Multiomics Analysis Identifies CAF-Derived Complement Factor B as a Prognostic Biomarker and Therapeutic Vulnerability in Breast Cancer. Hum Mutat. 2026;2026:2179334. [Google Scholar][Crossref]
- Ratre P, Thareja S, Mishra PK. Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients. Int Rev Cell Mol Biol. 2025;391:95-134. [Google Scholar][Crossref]
- Grisolia P, et al. Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation. J Transl Med. 2024;22(1):938. [Google Scholar][Crossref]
- Benkhalifa M, et al. Quantification of Free Circulating DNA and Differential Methylation Profiling of Selected Genes as Novel Non-Invasive Biomarkers for Endometriosis Diagnosis. Biomolecules. 2025;15(1). International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
- Ramezani A, et al. Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges. Arch Biochem Biophys. 2024;756:109994. [Google Scholar][Crossref]
- Katayama ES, et al. Stability of microRNAs in serum and plasma reveal promise as a circulating biomarker. Noncoding RNA Res. 2025;15:132-141. [Google Scholar][Crossref]
- Al-Abedi R, et al. Ionising Radiation Promotes Invasive Potential of Breast Cancer Cells: The Role of Exosomes in the Process. Int J Mol Sci. 2021;22(21). [Google Scholar][Crossref]
- Abedi A, et al. Exosomes as a Therapeutic Strategy in Cancer: Potential Roles as Drug Carriers and Immune Modulators. Biochim Biophys Acta Rev Cancer. 2025;1880(1):189238. [Google Scholar][Crossref]
- Blaser MC, Aikawa E. Differential miRNA Loading Underpins Dual Harmful and Protective Roles for Extracellular Vesicles in Atherogenesis. Circ Res. 2019;124(4):467-469. [Google Scholar][Crossref]
- Saadh MJ, et al. Exosomal microRNAs in cancer metastasis: A bridge between tumor micro and macroenvironment. Pathol Res Pract. 2024;263:155666. [Google Scholar][Crossref]
- Ma H, et al. Exosomal miR-20b-5p Induces EMT and Enhances Progression in Non-Small Cell Lung Cancer Via TGFBR2 Downregulation. J Biochem Mol Toxicol. 2024;38(12):e70080. [Google Scholar][Crossref]
- Lv M, et al. Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-beta signaling pathway. Int J Biol Macromol. 2024;275(Pt 1):133594. [Google Scholar][Crossref]
- Su Y, et al. Exosomes from miR-21-5p-modified adipose-derived stem cells promote wound healing by regulating M2 macrophage polarization in a rodent model of pressure ulcer. J Mol Histol. 2025;56(3):135. [Google Scholar][Crossref]
- Chen H, et al. Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells. BMC Cancer. 2022;22(1):1039. [Google Scholar][Crossref]
- Cheon I, et al. miR-200-mediated inactivation of cancer-associated fibroblasts via targeting of NRP2-VEGFR signaling attenuates lung cancer invasion and metastasis. Mol Ther Nucleic Acids. 2024;35(2):102194. [Google Scholar][Crossref]
- He H, et al. Exosomal miRNA as a biomarker for diagnosis and prognosis, and a new target for regulating treatment resistance in DLBCL: a research progress narrative review. Transl Cancer Res. 2026;15(5):438. [Google Scholar][Crossref]
- Wu Y, et al. Exosomal miR-1470 is a diagnostic biomarker and promotes cell proliferation and metastasis in colorectal cancer. Cancer Med. 2024;13(7):e7117. [Google Scholar][Crossref]
- Kumar RMR. Exosomal microRNAs: impact on cancer detection, treatment, and monitoring. Clin Transl Oncol. 2025;27(1):83-94. [Google Scholar][Crossref]
- Liu J, et al. Plasma exosomes may mediate the development of lupus nephritis in patients with systemic lupus erythematosus. Lupus. 2024;33(14):1573-1583. [Google Scholar][Crossref]
- Pei W, et al. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization. Gene. 2023;885:147692. [Google Scholar][Crossref]
- Jang JY, et al. Multiple microRNAs as biomarkers for early breast cancer diagnosis. Mol Clin Oncol. 2021;14(2):31. [Google Scholar][Crossref]
- Li J, et al. The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications. Breast Cancer (Dove Med Press). 2023;15:825-840. [Google Scholar][Crossref]
- Gao Y, et al. Transcriptional profiling of exosomes derived from serum of patients with rare earth pneumoconiosis by RNA-sequencing and PI3K/Akt pathway is activated in lung of mice exposed to rare earth Nd(2)O(3). Toxicol Lett. 2025;404:9-19. [Google Scholar][Crossref]
- Zhou W, et al. Healthy Plasma Exosomes Exert Potential Neuroprotective Effects against Methylmalonic Acid-Induced Hippocampal Neuron Injury. ACS Chem Neurosci. 2024;15(16):3022-3033. [Google Scholar][Crossref]
- Zhang X, et al. Healthy Tendon Stem Cell-Derived Exosomes Promote Tendon-To-Bone Healing of Aged Chronic Rotator Cuff Tears by Breaking the Positive-Feedback Cross-Talk between Senescent Tendon Stem Cells and Macrophages through the Modulation of Macrophage Polarization. Small. 2024;20(31):e2311033. [Google Scholar][Crossref]
- Filby S, et al. E-cigarette, cannabis, hookah and tobacco use patterns in fee-paying South African high schools. S Afr Med J. 2026;116(1):e3847. [Google Scholar][Crossref]
- Bai Y, et al. Hypersonic levitation and spinning: paving the way for enhanced single-cell analysis via contactless tissue dissociation. Commun Eng. 2025;4(1):167. [Google Scholar][Crossref]
- Marsh SE, et al. Author Correction: Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain. Nat Neurosci. 2025;28(1):215. [Google Scholar][Crossref]
- Batool SM, et al. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Cell Rep Med. 2023;4(10):101198. [Google Scholar][Crossref]
- Abe K, et al. Pancreatic Cancer in Hereditary Breast and Ovarian Cancer Syndrome: Is Early Detection Possible? Keio J Med. 2025;74(3):146-150. [Google Scholar][Crossref]
- Spector BL, et al. The methylome and cell-free DNA: current applications in medicine and pediatric disease. Pediatr Res. 2023;94(1):89-95. [Google Scholar][Crossref]
- Chen G, et al. Human breast milk-derived exosomes and their positive role on neonatal intestinal health. Pediatr Res. 2025. [Google Scholar][Crossref]
- Abdulmalek O, et al. Therapeutic Applications of Stem Cell-Derived Exosomes. Int J Mol Sci. 2024;25(6). [Google Scholar][Crossref]
- Al-Abedi R, et al. Therapeutic Fractional Doses of Ionizing Radiation Promote Epithelial-Mesenchymal Transition, Enhanced Invasiveness, and Altered Glycosylation in MCF-7 Breast Cancer Cells. Genome Integr. 2023;14:e20230001. [Google Scholar][Crossref]
- Saadh MJ, et al. Exosomes and MicroRNAs: key modulators of macrophage polarization in sepsis pathophysiology. Eur J Med Res. 2025;30(1):298. [Google Scholar][Crossref]
- Choudhary A, et al. Identification of novel exosomal miRNAs and their role in diagnosis and prognosis of triple negative breast cancer. BMC Cancer. 2026;26(1):210. [Google Scholar][Crossref]
- Du F, et al. The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper. Cancer Innov. 2025;4(4):e70013. International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
- Jang SY, et al. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. Ann Lab Med. 2021;41(3):302-309. [Google Scholar][Crossref]
- Nguyen CM, et al. Placental Exosomes as Biomarkers for Maternal Diseases: Current Advances in Isolation, Characterization, and Detection. ACS Sens. 2023;8(7):2493-2513. [Google Scholar][Crossref]
- Cheng S, et al. Advances in microfluidic extracellular vesicle analysis for cancer diagnostics. Lab Chip. 2021;21(17):3219-3243. [Google Scholar][Crossref]
- Chen J, et al. Recent Advances in Microfluidic-Based Extracellular Vesicle Analysis. Micromachines (Basel). 2024;15(5). [Google Scholar][Crossref]
- Mousavi SM, et al. Microfluidics for detection of exosomes and microRNAs in cancer: State of the art. Mol Ther Nucleic Acids. 2022;28:758-791. [Google Scholar][Crossref]
- Bieniasz-Krzywiec P, et al. Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer. Cell Metab. 2019;30(5):917-936.e10. [Google Scholar][Crossref]
- Scognamiglio I, et al. Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer. Mol Ther Nucleic Acids. 2022;28:17-31. [Google Scholar][Crossref]
- Zhang Q, et al. Plasma Soluble Podoplanin as a Biomarker of Hypercoagulability and Cellular Immunity Status in Patients With Non-small Cell Lung Cancer. Clin Appl Thromb Hemost. 2023;29:10760296231183432. [Google Scholar][Crossref]
- Charoenkwan P, et al. Deepstack-ACE: A deep stacking-based ensemble learning framework for the accelerated discovery of ACE inhibitory peptides. Methods. 2025;234:131-140. [Google Scholar][Crossref]
- Zhang Q, et al. Exosomes as Powerful Biomarkers in Cancer: Recent Advances in Isolation and Detection Techniques. Int J Nanomedicine. 2024;19:1923-1949. [Google Scholar][Crossref]
- Yu J, et al. Optimizing Conditions of Polyethylene Glycol Precipitation for Exosomes Isolation From MSCs Culture Media for Regenerative Treatment. Biotechnol J. 2024;19(9):e202400374. [Google Scholar][Crossref]
- Rahmatinejad F, et al. Comparison of morphology, protein concentration, and size distribution of bone marrow and Wharton's jelly-derived mesenchymal stem cells exosomes isolated by ultracentrifugation and polymer-based precipitation techniques. Tissue Cell. 2024;88:102427. [Google Scholar][Crossref]
- Larrea E, et al. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int J Mol Sci. 2016;17(5). [Google Scholar][Crossref]
- Chandel DS, et al. Preanalytical considerations for clinical assays of circulating human miRNA-451a, miRNA-423-5p and miRNA-199a-3p for diagnostic purposes. PLoS One. 2024;19(5):e0303598. [Google Scholar][Crossref]
- Kyriakidis I, Pelagiadis I, Stiakaki E. Pre-analytical considerations for microRNA quantification in childhood leukemia research. J Biol Methods. 2025;12(2):e99010062. [Google Scholar][Crossref]
How to Cite
AL-Abedi, R. A. (2026). Predictive Pre-Cancerous Biomarkers in BRCA1/2 Mutation Carriers: From Tissue-Resident Pre-CAFs to Blood-Based Exosomal Cargo. International Journal of Medical and All Body Health Research, 7(3), 106-114. https://doi.org/10.54660/IJMBHR.2026.7.3.106-114
AL-Abedi, Raheem A. "Predictive Pre-Cancerous Biomarkers in BRCA1/2 Mutation Carriers: From Tissue-Resident Pre-CAFs to Blood-Based Exosomal Cargo." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 106-114. https://doi.org/10.54660/IJMBHR.2026.7.3.106-114.
AL-Abedi, R. A. (2026) 'Predictive Pre-Cancerous Biomarkers in BRCA1/2 Mutation Carriers: From Tissue-Resident Pre-CAFs to Blood-Based Exosomal Cargo', International Journal of Medical and All Body Health Research, 7(3), pp. 106-114. doi: 10.54660/IJMBHR.2026.7.3.106-114.
AL-Abedi RA. Predictive Pre-Cancerous Biomarkers in BRCA1/2 Mutation Carriers: From Tissue-Resident Pre-CAFs to Blood-Based Exosomal Cargo. International Journal of Medical and All Body Health Research. 2026;7(3):106-114. doi:10.54660/IJMBHR.2026.7.3.106-114
Similar Articles
- Effect of Implementing a Blood Group Matching Program for Rh (D, C, c, E, e) and Kell on Biochemical and Hematological Parameters in Beta Thalassemia Patients (βT) Vol 7, Issue 3 (2026)
- Risk Factors of Increasing Intra-Abdominal Pressure and Compartment Syndrome and Their Management in Post Emergency Laparotomies’ Patients Vol 7, Issue 3 (2026)
- A Comparative Study on the Efficacy and Safety of Autologous Serum Therapy versus Azathioprine in the Treatment of Chronic Spontaneous Urticaria at a Tertiary Healthcare Centre in Uttar Pradesh Vol 7, Issue 3 (2026)
- Spectrum of Etiopathogenesis of Acute Kidney Disease in Indoor Patients: A Prospective Observational Study from a Tertiary Care Centre in Rajasthan, India Vol 7, Issue 3 (2026)
- Assessment of Carpal Tunnel Syndrome (Cts) In Patients with Rheumatoid Arthritis in Basrah, South of Iraq Vol 7, Issue 3 (2026)
Find this Article on
Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASEA newly published article may take a few days to appear on these services.